In the same way, EP3 expression in glandular epithelial cells is linked to poor prognosis in endometrial cancer, where its inhibition shows anti-cancer effects, making it a promising diagnostic and therapeutic target [194]. The gene discussed is PTGER3; the disease is cancer.